Evidence map›Paper›PMID 33871076›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2021

Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2?

S Signa, A R Sementa, M C Coccia, C Pastorino, G Viglizzo, S Viola, S Volpi, C Occella, D Bleidl, M Acquila and 3 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

S SignaUOSD Centro Malattie Autoinfiammatorie e Immunodeficienze, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
A R SementaUOC Anatomia Patologica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
M C CocciaUOC Anatomia Patologica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
C PastorinoUOC Dermatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
G ViglizzoUOC Dermatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
S ViolaUOC Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
S VolpiUOSD Centro Malattie Autoinfiammatorie e Immunodeficienze, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
C OccellaUOC Dermatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
D BleidlUOC Dermatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
M AcquilaUOC Laboratori Analisi, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
E CastagnolaUOC Malattie Infettive, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
A RavelliDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
F ManunzaUOC Dermatologia, IRCCS Istituto Giannina Gaslini, Genoa, Italy.ORCID https://orcid.org/0000-0003-2852-5880
Istituto Giannina Gaslini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChilblainsCOVID-19CausalityHumansRecurrenceSARS-CoV-2ChilblainCOVID-19SARS-CoV2

Identifiers

PMID33871076
PMCPMC8251000
OpenAlexW3156525961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.